Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-09

Clinical Trial Update: Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 1]

View source ↗

Summary

This document reports on a Phase 1 clinical trial evaluating estramustine phosphate in combination with paclitaxel for prostate cancer that progressed after hor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estramustine (estramustine)
  • PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: NYU Langone Health | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED